Navigation Links
Pneumonia Effectively Treated with Short-Term Antibiotic Course

Recent research has revealed that taking antibiotics for three days rather than the usual concept of seven to 10 days is equally effective in the treatment of common pneumonia // .

According to researchers this could also help to curb the rising problem of antibiotic-resistant bacteria,

Lead researcher Dr. Jan M Prins, an internist in infectious diseases at the Academic Medical Center, in Amsterdam said,’The question is how long you should treat common pneumonia. It turns out that three days is sufficient in children, and we now find the same in adults.’

The research team compared the effectiveness of three days of amoxicillin treatment with eight days of treatment in adults in cases of mild to moderate-severe pneumonia.

119 patients who had improved after three days of treatment with intravenous amoxicillin, and then assigned oral amoxicillin or a placebo for five days were taken as the subjects of the study.v It was found that 93 percent of the patients treated for three day or eight days, got better. Prins said, ‘For patients who responded after three days of antibiotic treatment, you could stop antibiotics and the results were comparable for those treated for eight days.’

The advantage lay in the fact that patients do not have to take in more medication than necessary. ‘In addition, there is a relation between how many antibiotics are used in a community and the rate of resistance among bacteria,’ he said. ‘If you can reduce the use of antibiotics, you can reduce the rate of resistance.’

The results of the research have been published in the June 10 issue of the British Medical Journal.

However Prins has cautioned that all diseases treated with antibiotics cannot become candidates for short-course treatment.

According to Dr. John Paul, from the Royal Sussex County Hospital, in England, and author of an accompanying editorial in the journal, ‘There is a lack of clear evidence to allow clinicians to know the optimal duration of antibiotic therapy for many common infections. He added, ‘We know that some infections do require long-term therapy to prevent relapse. We know for others that short courses of antibiotics are as good as long courses.’

‘This concept is smart,’ said Philip Tierno Jr., director of clinical microbiology and immunology at New York University Medical Center. ‘It eliminates three big problems: The cost to individuals of some of these newer antibiotics, adverse reactions and complications, and the development of resistanc.’


'"/>




Related medicine news :

1. Toxin connected to Flesh-eating Pneumonia in Kids
2. A new Vaccine for Pneumonia
3. The After Effects Of Pneumonia
4. Acid Suppressive Drugs Found To Increase The Risk for Pneumonia
5. Tsunami Survivors Face Pneumonia Threat
6. New Vaccine Found To Be Effective In Reducing Childhood Pneumonia
7. Zinc Effective In Helping Kids Recover From Pneumonia
8. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
9. Pneumonia Claims 30 Lives In Pakistan
10. Pneumonia Vaccine Effective Among Children
11. Five Tribal Children Succumbs to Pneumonia in Orissa
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2017)... VA (PRWEB) , ... April 27, 2017 , ... ... application containerization, today announced an exhibitor sponsorship at MobileIron Live! 2017 ... and new technologies for an immersive, educational approach to helping organizations maximize the ...
(Date:4/27/2017)... , ... April 27, 2017 , ... Offering the purest ... an oil many times purer and more potent than the market has seen before. ... Gstaad, Switzerland, as well as a patented chromatography process for extraction, to produce its ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to announce that ... at the upcoming Aesthetic Meeting. Held in San Diego, at the San Diego Convention ... will lend their expertise to the Premier Global Hot Topics session, speaking on genital ...
(Date:4/26/2017)... Louis, Missouri (PRWEB) , ... April 26, 2017 ... ... cost, quality and clinical outcomes, today released the podcast, “Make Plans for ... in bringing value-based payment into the physician's office and how physicians and other ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... ATA 2017 President’s Awards recipients, comprised of organizations and individuals who have ... , The ATA 2017 President’s Awards recognize individuals and organizations on the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... and Gynecology markets with innovative and proprietary products, ... Company as Senior Vice President, Marketing & Business ... will report directly to Darin Hammers , ... delighted that Ash has joined the Cogentix team," ...
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: